These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6112253)

  • 1. Neurotransmitter defects and treatment of disorders of hyperphenylalaninemia.
    Butler IJ; O'Flynn ME; Seifert WE; Howell RR
    J Pediatr; 1981 May; 98(5):729-33. PubMed ID: 6112253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A disorder of biogenic amines in dihydropteridine reductase deficiency.
    Butler IJ; Koslow SH; Krumholz A; Holtzman NA; Kaufman S
    Ann Neurol; 1978 Mar; 3(3):224-30. PubMed ID: 27135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biogenic amine synthesis defect in dihydropteridine reductase deficiency.
    Koslow SH; Butler IJ
    Science; 1977 Nov; 198(4316):522-3. PubMed ID: 20665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental delay and non-phenylketonuria (PKU) hyperphenylalaninemia in DNAJC12 deficiency: Case and approach.
    Wong RSH; Mohammad S; Parayil Sankaran B; Junek R; Kim WT; Wotton T; Devanapalli B; Bandodkar S; Balasubramaniam S
    Brain Dev; 2023 Oct; 45(9):523-531. PubMed ID: 37156708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperphenylalaninemia due to dihydropteridine reductase deficiency. Assay of the enzyme in fibroblasts from affected infants, heterozygotes, and in normal amniotic fluid cells.
    Milstien S; Holtzman NA; O'Flynn ME; Thomas GH; Butler IJ; Kaufman S
    J Pediatr; 1976 Nov; 89(5):763-6. PubMed ID: 978323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary dihydroxanthopterin in the diagnosis of malignant hyperphenylalaninemia and phenylketonuria.
    Schlesinger P; Watson BM; Cotton RG; Danks DM
    Clin Chim Acta; 1979 Mar; 92(2):187-95. PubMed ID: 487572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis, treatment and gene mutation analysis of the first case with dihydropteridine reductase deficiency in the mainland of China].
    Ye J; Qiu WJ; Han LS; Zhang HW; Zhou JD; Gao XL; Wang Y; Gu XF
    Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):281-5. PubMed ID: 19099731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydropteridine reductase deficiency associated with severe neurologic disease and mild hyperphenylalaninemia.
    Brewster TG; Moskowitz MA; Kaufman S; Breslow JL; Milstien S; Abroms IF
    Pediatrics; 1979 Jan; 63(1):94-9. PubMed ID: 312482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction.
    Smith I; Clayton BE; Wolff OH
    Lancet; 1975 May; 1(7916):1108-11. PubMed ID: 49470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperphenylalaninaemia due to dihydropteridine reductase deficiency.
    Gröbe H; Bartholome K; Milstien S; Kaufman S
    Eur J Pediatr; 1978 Sep; 129(2):93-8. PubMed ID: 28230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by enzyme assays on dried blood spots.
    Arai N; Narisawa K; Hayakawa H; Tada K
    Pediatrics; 1982 Sep; 70(3):426-30. PubMed ID: 7110817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria.
    Kaufman S; Berlow S; Summer GK; Milstien S; Schulman JD; Orloff S; Spielberg S; Pueschel S
    N Engl J Med; 1978 Sep; 299(13):673-9. PubMed ID: 683251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two mutations of dihydropteridine reductase deficiency.
    Ponzone A; Guardamagna O; Ferraris S; Bracco G; Niederwieser A; Cotton RG
    Arch Dis Child; 1988 Feb; 63(2):154-7. PubMed ID: 2894818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrahydropterin therapy for hyperphenylalaninemia caused by defective synthesis of tetrahydrobiopterin.
    Kaufman S; Kapatos G; Rizzo WB; Schulman JD; Tamarkin L; Van Loon GR
    Ann Neurol; 1983 Sep; 14(3):308-15. PubMed ID: 6139056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenetic mechanisms in phenylketonuria: disorders affecting the metabolism of neurotransmitters and the antioxidant system].
    Ormazábal A; Artuch R; Vilaseca MA; García-Cazorla A; Campistol J
    Rev Neurol; 2004 Nov 16-30; 39(10):956-61. PubMed ID: 15573314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperphenylalaninemia--clinical features, biochemical findings, and experience with administration of biopterins.
    Danks DM; Schlesinger P; Firgaira F; Cotton RG; Watson BM; Rembold H; Hennings G
    Pediatr Res; 1979 Oct; 13(10):1150-5. PubMed ID: 503643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
    Kure S; Hou DC; Ohura T; Iwamoto H; Suzuki S; Sugiyama N; Sakamoto O; Fujii K; Matsubara Y; Narisawa K
    J Pediatr; 1999 Sep; 135(3):375-8. PubMed ID: 10484807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biogenic amines and hyperphenylalaninemia (author's transl)].
    Tada K; Narisawa K
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1765-71. PubMed ID: 7029642
    [No Abstract]   [Full Text] [Related]  

  • 19. Recovery of neurogenic amines in phenylketonuria mice after liver-targeted gene therapy.
    Yagi H; Sanechika S; Ichinose H; Sumi-Ichinose C; Mizukami H; Urabe M; Ozawa K; Kume A
    Neuroreport; 2012 Jan; 23(1):30-4. PubMed ID: 22107842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrahydrobiopterin loading test in hyperphenylalaninemia.
    Ponzone A; Guardamagna O; Ferraris S; Ferrero GB; Dianzani I; Cotton RG
    Pediatr Res; 1991 Nov; 30(5):435-8. PubMed ID: 1754298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.